IZOPROSTANY - NOWE BIOMARKERY LIPIDOWEJ PEROKSYDACJI IN VIVO

Andrzej Tokarz; Małgorzata Jelińska; Agnieszka Ozga

doi:10.56782/pps.48

Published : 2004-04-19

Vol. 2 No. 2 (2004)

ISOPROSTANES - NEW BIOMARKERS IN LIPID PEROXIDATION IN VIVO

Andrzej Tokarz

Małgorzata Jelińska

Agnieszka Ozga

DOI: https://doi.org/10.56782/pps.48

Abstract

The discovery of isoprostanes, which are products of non-enzymatic lipid peroxidation, resulted in the research on the new role of free radicals in physiology and pathophysiology. Isoprostane quantitative analysis, by use of physical and immunological methods, is a great achievement in the evaluation of free radical impact on many diseases in human. Isoprostanes occur commonly in biological liquids such as urine, blood, cerebro-spinal fluid and in the air breathed out. For that reason attempts are made to apply isoprostanes in the diagnosis of chronic diseases, which may be caused by oxidative stress.
Quantification of isoprostanes also gives the possibilities to optimize the diet by supporting proper amounts of antioxidants and polyunsaturated fatty acids and by supplementation with beneficial components.

Keywords:

isoprostanes, biomarkers, oxidative stress

Most read articles by the same author(s)

Małgorzata Jelińska, FATTY ACIDS - CARCINOGENESIS MODIFYING FACTORS , Prospects in Pharmaceutical Sciences: Vol. 3 No. 1 (2005)
Małgorzata Idzikowska, Marta Janczura, Tomasz Lepionka, Michał Madej, Edyta Mościcka, Justyna Pyzik, Paulina Siwek, Weronika Szubierajska, Dorota Skrajnowska, Andrzej Tokarz, NANOTECHNOLOGY IN FOOD PRODUCTION – DEVELOPMENT, RISKS AND REGULATORY ASPECTS , Prospects in Pharmaceutical Sciences: Vol. 10 No. 4 (2012)
Agnieszka Białek, Andrzej Tokarz, DIETARY SOURCES AND BENEFICIAL HEALTH EFFECTS OF CONJUGATED LINOLEIC ACIDS (CLA) , Prospects in Pharmaceutical Sciences: Vol. 7 No. 1 (2009)
Katarzyna Czuba, Magdalena Mazurkiewicz, Kamil Kamiński, Filip Różewski, Dorota Skrajnowska, Andrzej Tokarz, BIOTERRORISM – THREAT, PREVENTIVE ACTIONS, INTERNATIONAL LAW , Prospects in Pharmaceutical Sciences: Vol. 9 No. 2 (2011)
Błażej Grodner, Małgorzata Jelińska, The method of direct determination of manganese in fresh parsley leaves and roots using capillary electrophoresis method. , Prospects in Pharmaceutical Sciences: Vol. 21 No. 1 (2023)
Paulina Brewczyńska, Justyna Makowska, Dorota Skrajnowska, Marta Teryks, Andrzej Tokarz, ADDICTION TO CONVENTIONAL AND ELECTRONIC CIGARETTES AND THE RISKS OF PHARMACOTHERAPY IN SMOKERS. , Prospects in Pharmaceutical Sciences: Vol. 13 No. 3 (2015)

Similar Articles

Dominika Łacheta, Wioletta Olejarz, OCHRONNA ROLA KWASU α-LIPONOWEGO W MIAŻDŻYCY I CHOROBACH SERCOWO-NACZYNIOWYCH , Prospects in Pharmaceutical Sciences: Vol. 17 No. 8 (2019)
Nazan Çömlekçioğlu, Nuh Korkmaz, Mehmet Ali Yüzbaşıoğlu, İmran Uysal, Mustafa Sevindik, Mistletoe (Loranthus europaeus Jacq.): antioxidant, antimicrobial and anticholinesterase activities , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Mateusz Sobczyk, Daria Żuraw, Paulina Oleksa, Kacper Jasiński, Mikołaj Porzak, Michał Dacka, SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
Jadwiga Piwowarska, Jolanta Felczak, Jacek Łukaszkiewicz, CONCENTRATION OF MALONDIALDEHYDE IN BLOOD AS AN INDICATOR IN LIVER TRANSPLANTATION , Prospects in Pharmaceutical Sciences: Vol. 14 No. 6 (2016)
Ali İmran Korkmaz, Celal Bal, Emre Cem Eraslan, Mustafa Sevindik, Hasan Akgul, Biological activities of Agrocybe praecox (spring fieldcap mushroom) , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Sylwia Osowska, Joanna Regulska, Lipid peroxidation markers used in parenteral nutrition , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Mayur Kadam, Nitin L. Jadhao, Jayant M. Gajbhiye, Synthesis of pyrazole and 1,3,4-oxadiazole derivatives of pharmaceutical potential , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Celal Bal, Emre Cem Eraslan, Mustafa Sevindik, Antioxidant, antimicrobial activities, total phenolic and element contents of wild edible mushroom Bovista nigrescens , Prospects in Pharmaceutical Sciences: Vol. 21 No. 2 (2023)
Piotr Wałejko, Stanisław Witkowski, POLYUNSATURATED FATTY ACIDS AND THEIR OXIDATION PRODUCTS , Prospects in Pharmaceutical Sciences: Vol. 14 No. 7 (2016)
Falah Saleh Mohammed, Eylem Kına, İmran Uysal, Mustafa Sevindik, Total phenolic, flavonoid contents, antioxidant and antimicrobial activities of Hesperis pendula , Prospects in Pharmaceutical Sciences: Vol. 21 No. 2 (2023)

1 2 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Tokarz, A., Jelińska, M., & Ozga, A. (2004). ISOPROSTANES - NEW BIOMARKERS IN LIPID PEROXIDATION IN VIVO. Prospects in Pharmaceutical Sciences, 2(2), 10–17. https://doi.org/10.56782/pps.48

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

Rokach J., Khanapure S.P., Hwang S.W., Adiyamen M., Lawson J.A., FitzGerald G.A.: The Isoprostanes Perspective. Prostaglandins. 1997;54,6,823-851. DOI: https://doi.org/10.1016/S0090-6980(97)00183-4

de Zwart L.L., Meerman J.H., Commandeur J.N., Vermeuln N.H.: Biomarkers of Free Radical Damage Applications in Experimental Animals and in Humans. Free Redical Biology&Medicine 1999;26,1-2,202-226. DOI: https://doi.org/10.1016/S0891-5849(98)00196-8

Mayes P.A.: Metabolizm nienasyconych kwasów tłuszczowych i eikozanoidów. Biochemia Harpera. Wydawnictwo Lekarskie PZWL, Warszawa 1995;275-283.

Morrow J.W., Chen Y., Brame C.J., Yang J., Sanchez S.C., Xn J., Zeckert W.E.: The Isoprostanes: Unique Prostaglandin – like Products of Free Radical Initiated Lipid Peroxidation. Drug Metabolism Reviews 1999;31,1,117-139. DOI: https://doi.org/10.1081/DMR-100101910

England T., Bealty E., Rehman A., Nourooz-Zadek J., Pereira P., O’Reily J.: The Steady-State Levels of Oxidative DNA Damage and of Lipids Peroxidation (F2-Isoprostanes) are not Correlated in Healthy Human Subjects. Free Redical Research, 2000;32,4,355-362. DOI: https://doi.org/10.1080/10715760000300351

Lawson J.A., Rokach J., FitzGerald G.A.: Isoprostanes: Formation, Analysis and Use as Indices of Lipid Peroxidation in Vivo. J.Biol.Chem. 1999;274,35,24441-24444. DOI: https://doi.org/10.1074/jbc.274.35.24441

Rokach J., Khanapure S.P., Hwang S.W., Adiyaman M., Lawson J.A., FitzGerald G.A.: Nomenclature of Isoprostanes: A Proposol. Prostaglandins, 1997;54,6,853-873. DOI: https://doi.org/10.1016/S0090-6980(97)00184-6

Nourooz-Zadeh J., Halliwell B., Anggard E.E.: Evidence for the Formation of F3-Isoprostanes During Peroxidation of Eicosapentaenoic Acid. Biochemical and Biophysical Research Communications. 1997;236,2,467-472. DOI: https://doi.org/10.1006/bbrc.1997.6869

Imbush R., Muller MD: Formation of Isoprostanes F(2) – like Compounds (Phytoprostane F(1) – from -Linolenic Acid in Plants. Free Radical Biology&Medicine 2000;28,5,720-726. DOI: https://doi.org/10.1016/S0891-5849(00)00154-4

Heagher E.A., FitzGerald G.A.: Indices of Lipid Peroxidation in Vivo: Strenghts and Limitations. Free Radical Biology&Medicine. 2000;28,12,1745-1750. DOI: https://doi.org/10.1016/S0891-5849(00)00232-X

Roberts L.J., Morrow J.D.: The Generation and Action of Isoprostanes. Biochemia et Biophysica Acta. 1997;1345,2,121-135. DOI: https://doi.org/10.1016/S0005-2760(96)00162-2

Takahashi K., Nammour T.M., Fukunaga M., Ebert J., Morrow J.D., Roberts LJII, Hoover R.L., Badr K.F.: Glomerular actions of a free redical-generated novel prostaglandin, 8-epi-prostaglandin F2, in the rat: evidence for interaction with thromboxane A2 receptors. J.Clin. Invest. 1992;90,136-141. DOI: https://doi.org/10.1172/JCI115826

Fukunaga M., Makita N., Roberts LJII, Morrow J.D., Takahashi k., Badr K.F.: Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am. J. Physiol. 1983;264,C1619-1624. DOI: https://doi.org/10.1152/ajpcell.1993.264.6.C1619

Kunapuli P., Lawson I.A., Rokach J.A., FitzGerald G.A.: Functional characterization of the ocular PGF2 receptor: activation by the isoprostane 12-epi-PGF2. J. Biol Chem. 1997;272,27147-27154. DOI: https://doi.org/10.1074/jbc.272.43.27147

Ferro D., Basili S.,Pratico D., Julieno L., FitzGerald G.A., Violi F.: Vitamin E reduces monocyte tissue factor expression in cirrhotic patients. Blood 1999;93,2945-2950. DOI: https://doi.org/10.1182/blood.V93.9.2945

Roberts L.J., Morrow J.D.: Measurements of F2 – Isoprostanes as an Index of Oxidative Stress in Vivo. Free Radical Biology&Medicine 2000;28,4,505-513. DOI: https://doi.org/10.1016/S0891-5849(99)00264-6

Souvignet C., Cracowski J.L., Stanke-Labesque F., Bessard G.: Are Isoprostans a Clinical Marker for Antioxidant Drug Investigation. Fundamental&Clinical Pharmacology, 2000;14,1,1-10. DOI: https://doi.org/10.1111/j.1472-8206.2000.tb00387.x

Pratico D., Lee M-Y, Trojanowski J.Q., Rokach J., FitzGerald G.A.: Increased F2 – Isoprostanes in Alzheimer’s Disease: Evidence for Enhanced Lipid Peroxidation in Vivo. FASEB J. 1998;12,1777-1783. DOI: https://doi.org/10.1096/fasebj.12.15.1777

Geco A., Minghetti L., Levi G.: Isoprostanes, Novel Markers of Oxidative Injury Help Understanding the Pathogenesis of Neurodegenerative Diseases. Neurochemical Research,2000; 25,9-10,1357-1364. DOI: https://doi.org/10.1023/A:1007608615682

Meagher E.A., Barry O.P., Burke A., Lucey M.R., Lawson J.A., Rokach J.U., FitzGerald G.A.: Alcohol – Induced Generation of Lipid Peroxidation Products in Humans. Journal of Clinical Investigation 1998;104,6,805-813. DOI: https://doi.org/10.1172/JCI5584

Obwegeser R., Oguogho A., Ulm H., Berghammer P., Sinzinger H.: Maternal Cigarette Smoking Increases F2 – Isoprostanes and Reduces Prostacyclin and Nitric Oxide in Umbilical Vassels. Prostaglandins&Other Lipid Mediators 1999;57,4,269-279. DOI: https://doi.org/10.1016/S0090-6980(99)00011-8

Davi G., Alessandrini P., Mezzetti A., Minotti G., Bucciarelli T., Constantini F., Cipollone F., Ciabattoni G., Patrono C.: In vivo of 8.epi – Prostaglandin F2 is Increased in Hypercholesterolemia. Arteriosclerosis, Thrombosis and Vascular Biology, 1997;17,11,3230-3235. DOI: https://doi.org/10.1161/01.ATV.17.11.3230

Gniwotta C., Morrow J.W., Roberts L.J., Kuhn H.: Prostaglandin F2 – like compounds, F2 – Isoprotanes are Present in Inceused Amonats in Human Atherosclerotic Lesions. Arteriosclerosis, Thrombosis and Vescular Biology, 1997;17,11,3236-3241. DOI: https://doi.org/10.1161/01.ATV.17.11.3236

Wood L.G., FitzGerald D.A., Gibson P.G., Cooper D.M., Garg M.L.: Lipid Peroxidation as Determined by Plasma Isoprostanes is Related to Diseuse Severity in Mild Asthma. Lipids 2000;35,9,967-974. DOI: https://doi.org/10.1007/s11745-000-0607-x

Pretico D., Basili S., Vieri M., Cordova C., Violi F., FitzGerald G.A. : Chronic Obstructive Pulmonary Disease is Associated with on Increuse in Urinary Levels of Isoprotane F-III, an Index of Oxidant Stress. Am. J. Respir. Crit. Care Med. 1998;158,1709-1714. DOI: https://doi.org/10.1164/ajrccm.158.6.9709066

Montuschi P., Ciabattoni G., Paredi P., Pantelidis P., du Bois R.M., Kharitonov S.A., Barnes P.J.: 8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases. Am. J. Respir. Crit. Care Med. 1998; 158, 1524-1527. DOI: https://doi.org/10.1164/ajrccm.158.5.9803102

Davi G., Ciabattoni G., Consoli A., Mezetti A., Falco A., Santarone S., Pennese E., Vitacolonna E., Bucciarelli T., Patrono G.: In Vivo Formation of 8-iso Prostaglandin F2 alpha and Platelet Acivation in Diabetes Mallitus: Effect of Improved Metabolic Control and Vitamin E Supplementation. Circulation 1999;99,22,224-229. DOI: https://doi.org/10.1161/01.CIR.99.2.224

Bułhak-Jachymczyk B., Niedźwiecka-Kącik D., Penczenko-Kresowska B., Wartanowicz M., Ziemlański Ś.: Normy żywienia człowieka – fizjologiczne podstawy. Wydawnictwo Lekarskie PZWL, I, 2001;78-432.

Hesik J.: Usprawnienia dietetyczne procesów metabolicznych. Co to są fitaminy? Postępy Fitoterapii 2001;6(2-3),9-11.

Greenwald P., Clifford C.K., Milner J.A.: Diet and cancer prevention. European J. of Cancer 2001; 37, 948-965. DOI: https://doi.org/10.1016/S0959-8049(01)00070-3

Troszyńska A., Honke J., Kozłowska H.: Naturalne substancje nieodżywcze (NSN) pochodzenia roślinnego jako składniki żywności funkcjonalnej. Postępy Fitoterapii 2000;2,17-21.

Andrzej Tokarz

Affiliation:

Katedra i Zakład Bromatologii, Wydział Farmaceutyczny Akademii Medycznej w Warszawie Poland

Małgorzata Jelińska

Affiliation:

Katedra i Zakład Bromatologii, Wydział Farmaceutyczny Akademii Medycznej w Warszawie Poland

Agnieszka Ozga

Affiliation:

Katedra i Zakład Bromatologii, Wydział Farmaceutyczny Akademii Medycznej w Warszawie Poland